| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Vineeta Singh, Melissa Carman, Jochen Roeper, Antonello Bonc. Brief ischemia causes long-term depression in midbrain dopamine neurons. The European journal of neuroscience. vol 26. issue 6. 2007-11-20. PMID:17880389. |
degeneration of dopamine neurons in the substantia nigra pars compacta (snc) plays an important role in the pathophysiology of neurodegenerative diseases like parkinsonism and vascular dementia. |
2007-11-20 |
2023-08-12 |
rat |
| Ennio Esposito, Vincenzo Di Matteo, Arcangelo Benigno, Massimo Pierucci, Giuseppe Crescimanno, Giuseppe Di Giovann. Non-steroidal anti-inflammatory drugs in Parkinson's disease. Experimental neurology. vol 205. issue 2. 2007-07-10. PMID:17433296. |
parkinson's disease (pd) is known to be a chronic and progressive neurodegenerative disease caused by a selective degeneration of dopaminergic (daergic) neurons in the substantia nigra pars compacta (snc). |
2007-07-10 |
2023-08-12 |
Not clear |
| Shin-ichiro Kubo, Nobutaka Hattori, Yoshikuni Mizun. Recessive Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society. vol 21. issue 7. 2006-12-15. PMID:16615060. |
parkinson's disease (pd) is a progressive neurodegenerative disease caused by loss of dopaminergic neurons in the substantia nigra pars compacta. |
2006-12-15 |
2023-08-12 |
Not clear |
| Anil Kumar, S K Kulkarn. Effect of BR-16A (Mentat), a polyherbal formulation on drug-induced catalepsy in mice. Indian journal of experimental biology. vol 44. issue 1. 2006-03-02. PMID:16430090. |
parkinson's disease (pd) is a neurodegenerative disease characterized by the selective loss of dopamine (da) neurons of the substantia nigra pars compacta (snc). |
2006-03-02 |
2023-08-12 |
mouse |
| Fleur M Howells, Vivienne A Russell, Musa V Mabandla, Lauriston A Kellawa. Stress reduces the neuroprotective effect of exercise in a rat model for Parkinson's disease. Behavioural brain research. vol 165. issue 2. 2006-02-09. PMID:16159673. |
parkinson's disease (pd) is a progressive neurodegenerative disease of nigrostriatal dopamine (da) neurons that project from the substantia nigra pars compacta (snc) to the striatum. |
2006-02-09 |
2023-08-12 |
rat |
| V Jackson-Lewis, R J Smeyn. MPTP and SNpc DA neuronal vulnerability: role of dopamine, superoxide and nitric oxide in neurotoxicity. Minireview. Neurotoxicity research. vol 7. issue 3. 2005-07-15. PMID:15897154. |
parkinson disease (pd) is a common neurodegenerative disease of unknown origin that is characterized, mainly, by a significant reduction in the number of dopamine neurons in the substantia nigra pars compacta (snpc) of the brain and a dramatic reduction in dopamine levels in the corpus striatum. |
2005-07-15 |
2023-08-12 |
Not clear |
| Pavan K Auluck, Marc C Meulener, Nancy M Bonin. Mechanisms of Suppression of {alpha}-Synuclein Neurotoxicity by Geldanamycin in Drosophila. The Journal of biological chemistry. vol 280. issue 4. 2005-03-08. PMID:15556931. |
parkinson's disease is a common neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta and the accumulation of the protein alpha-synuclein into aggregates called lewy bodies and lewy neurites. |
2005-03-08 |
2023-08-12 |
drosophila_melanogaster |
| L Tenenbaum, A Chtarto, E Lehtonen, D Blum, V Baekelandt, T Velu, J Brotchi, M Levivie. Neuroprotective gene therapy for Parkinson's disease. Current gene therapy. vol 2. issue 4. 2003-05-14. PMID:12477256. |
parkinson's disease (pd) is a neurodegenerative disease characterised by a progressive loss of the dopaminergic neurones in the substantia nigra pars compacta. |
2003-05-14 |
2023-08-12 |
mouse |
| H Tohgi, S Takahashi, T Abe, K Utsugisaw. Symptomatic characteristics of parkinsonism and the width of substantia nigra pars compacta on MRI according to ischemic changes in the putamen and cerebral white matter: implications for the diagnosis of vascular parkinsonism. European neurology. vol 46. issue 1. 2001-09-06. PMID:11455176. |
to investigate the significance of vascular lesions as a cause of secondary parkinsonism, we analyzed the symptomatic characteristics, the width of the substantia nigra pars compacta (snpc) on mri and the responsiveness to l-dopa in 227 parkinsonian cases, excluding those with drug-induced parkinsonism and neurodegenerative diseases other than idiopathic parkinson's disease (ipd). |
2001-09-06 |
2023-08-12 |
Not clear |
| H Allain, D Bentué-Ferre. [Parkinson disease: interrogations and solutions]. Presse medicale (Paris, France : 1983). vol 26. issue 19. 1997-08-04. PMID:9232065. |
a neurodegenerative disease: idiopathic parkinson's disease is initially due to a selective and specific destruction of the pars compacta dopaminergic neurons in substantia nigra. |
1997-08-04 |
2023-08-12 |
Not clear |